Vestmark Advisory Solutions, Inc. Beam Therapeutics Inc. Transaction History
Vestmark Advisory Solutions, Inc.
- $6.16 Billion
- Q2 2025
A detailed history of Vestmark Advisory Solutions, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 323,000 shares of BEAM stock, worth $8.2 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
323,000
Previous 154,521
109.03%
Holding current value
$8.2 Million
Previous $3.02 Million
82.1%
% of portfolio
0.09%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding BEAM
# of Institutions
245Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$254 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$246 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$225 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$194 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$120 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.79B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...